Hoechst Aktiengesellschaft

Sanofi

Sanofi-a Ventis Deutschland Gmbh

Jens Stechl

Franz Hock

Hansjorg Urbach

Rainer Henning

Jochen Knolle

Bernward Scholkens

Gerhard Breipohl

Hans-Wolfram Fehlhaber

Stephan Henke

Hermann J Gerhards

Wolfgang Ruger

Hiristo Anagnostopulos

Patricia Usinger

Christophe Gaudin

Angele Moryusef

Pascale Ythier-Moury

Claudia Pfeiffer

Irene Nowotny

Jean-Louis Pinquier

The invention relates to the use of (2R,3R)-2-(3-carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in non-ST elevation myocardial infarction, said treatment comprising administering a therapeutically effective amount of (2R,3R)-2-(3-Carbamimidoyl-benzyl)-3-[4-(1-oxy-pyridin-4-yl)benzoylamino]-butyric acid methyl ester or a pharmaceutically acceptable salt thereof to a human patient, who is elderly and/or shows renal insufficiency and/or has a low body weight.

Otamixaban for treatment of elderly and renal impaired non-ST elevation myocardial infarction patients

Peptides having bradykinin antagonist action

Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system. The invention relates to the use of angiotensin converting enzyme inhibitors as pharmaceuticals with a psychotropic, especially anxiolytic, action, to agents containing them, and to the use thereof for the treatment or prophylaxis of disorders of the central nervous system, especially of anxiety states. The invention also relates to new compounds of the formula ##STR1## in which R.sup.2 denotes hydrogen or ethyl, and R.sup.3 denotes n-octyl, to processes for the preparation thereof, to agents containing them, and to the use thereof as pharmaceuticals.

Compounds with a psychotropic action, agents containing them, and the

Growing community of inventors

Frankfurt am Main, Germany

Jens Stechl